This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Jie Wu - Innovator in Pharmaceutical Chemistry
Introduction
Jie Wu is a notable inventor based in Zhenjiang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that have therapeutic applications.
Latest Patents
Jie Wu holds 1 patent for a 2-aryl selenazole compound and its pharmaceutical composition. This compound is represented by a specific formula and is known for its ability to inhibit xanthine oxidase. The applications of this compound include the prevention and treatment of hyperuricemia, gout, diabetic nephropathy, inflammatory diseases, and neurological disorders.
Career Highlights
Throughout his career, Jie Wu has worked with prominent companies in the pharmaceutical industry, including Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. and Atom Bioscience and Pharmaceutical Co. Ltd. His work has been instrumental in advancing drug development and improving therapeutic options for various medical conditions.
Collaborations
Jie Wu has collaborated with several professionals in his field, including Dongfang Shi and Changjin Fu. These collaborations have contributed to the successful development of his patented compounds and have enhanced the research efforts in pharmaceutical sciences.
Conclusion
Jie Wu's innovative contributions to pharmaceutical chemistry highlight his role as a key inventor in the industry. His work on the 2-aryl selenazole compound demonstrates the potential for new treatments in various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile